scholarly article | Q13442814 |
P819 | ADS bibcode | 2006PNAS..103.2641B |
P356 | DOI | 10.1073/PNAS.0511136103 |
P932 | PMC publication ID | 1413831 |
P698 | PubMed publication ID | 16481622 |
P5875 | ResearchGate publication ID | 7294695 |
P50 | author | Hans-Georg Kräusslich | Q1576991 |
Per Haberkant | Q55473989 | ||
Bärbel Glass | Q123962584 | ||
P2093 | author name string | Britta Brügger | |
Felix T Wieland | |||
Iris Leibrecht | |||
P2860 | cites work | The membrane domains occupied by glycosylphosphatidylinositol-anchored prion protein and Thy-1 differ in lipid composition | Q48123171 |
Two dimensional then layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots. | Q48919839 | ||
Analysis of sphingomyelin, glucosylceramide, ceramide, sphingosine, and sphingosine 1-phosphate by tandem mass spectrometry. | Q52926527 | ||
Quantitative Analysis of Phospholipids in Functionally Important Membrane Domains from RBL-2H3 Mast Cells Using Tandem High-Resolution Mass Spectrometry† | Q57365119 | ||
Cholesterol is Required for the Formation of Regulated and Constitutive Secretory Vesicles from the trans-Golgi Network | Q57369463 | ||
Separation and characterization of the unknown phospholipid in human lens membranes | Q71991234 | ||
Epitope mapping and topology of baculovirus-expressed HIV-1 gp160 determined with a panel of murine monoclonal antibodies | Q72146275 | ||
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION | Q25939000 | ||
Lipid rafts and signal transduction | Q28131735 | ||
Role of LBPA and Alix in multivesicular liposome formation and endosome organization | Q28240220 | ||
Model systems, lipid rafts, and cell membranes | Q28261365 | ||
Membrane properties of D-erythro-N-acyl sphingomyelins and their corresponding dihydro species | Q28363726 | ||
Plasmalogens: biosynthesis and functions | Q28609417 | ||
Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone | Q29547734 | ||
Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay | Q29619255 | ||
Plasma membrane rafts play a critical role in HIV-1 assembly and release | Q33950207 | ||
Lipid rafts: elusive or illusive? | Q33973937 | ||
Lipid composition and fluidity of the human immunodeficiency virus | Q34048036 | ||
The stoichiometry of Gag protein in HIV-1. | Q34328141 | ||
Resistance of cell membranes to different detergents | Q35022104 | ||
Molecular dynamics and interactions for creation of stimulation-induced stabilized rafts from small unstable steady-state rafts | Q35696745 | ||
Quantitative analysis of biological membrane lipids at the low picomole level by nano-electrospray ionization tandem mass spectrometry | Q36040256 | ||
Detecting microdomains in intact cell membranes | Q36083041 | ||
Lipid composition and fluidity of the human immunodeficiency virus envelope and host cell plasma membranes | Q36342211 | ||
Evidence for segregation of sphingomyelin and cholesterol during formation of COPI-coated vesicles | Q36342546 | ||
Biochemical and structural analysis of isolated mature cores of human immunodeficiency virus type 1. | Q39588178 | ||
Semliki forest virus budding: assay, mechanisms, and cholesterol requirement | Q39592862 | ||
Structural organization of authentic, mature HIV-1 virions and cores | Q39744816 | ||
Construction and characterization of a fluorescently labeled infectious human immunodeficiency virus type 1 derivative | Q39991984 | ||
Properties of palmitoyl phosphatidylcholine, sphingomyelin, and dihydrosphingomyelin bilayer membranes as reported by different fluorescent reporter molecules | Q40228945 | ||
Cholesterol in Bilayers of Sphingomyelin or Dihydrosphingomyelin at Concentrations Found in Ocular Lens Membranes | Q40235761 | ||
Intra-Golgi Protein Transport Depends on a Cholesterol Balance in the Lipid Membrane | Q40625738 | ||
Virion-associated cholesterol is critical for the maintenance of HIV-1 structure and infectivity. | Q40688664 | ||
Lipid rafts are enriched in arachidonic acid and plasmenylethanolamine and their composition is independent of caveolin-1 expression: a quantitative electrospray ionization/mass spectrometric analysis | Q40752849 | ||
Quantitative determination of phospholipid compositions by ESI-MS: effects of acyl chain length, unsaturation, and lipid concentration on instrument response. | Q40814316 | ||
Influenza viruses select ordered lipid domains during budding from the plasma membrane | Q40980312 | ||
Inhibition of sphingolipid biosynthesis by fumonisins. Implications for diseases associated with Fusarium moniliforme | Q43480875 | ||
Role of lipid rafts in virus replication | Q45424163 | ||
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | HIV | Q15787 |
P304 | page(s) | 2641-2646 | |
P577 | publication date | 2006-02-15 | |
P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
P1476 | title | The HIV lipidome: a raft with an unusual composition | |
P478 | volume | 103 |
Q44018489 | 13C-13C and (15)N-(13)C correlation spectroscopy of membrane-associated and uniformly labeled human immunodeficiency virus and influenza fusion peptides: amino acid-type assignments and evidence for multiple conformations |
Q92453927 | A bipartite structural organization defines the SERINC family of HIV-1 restriction factors |
Q33796283 | A critical role for ceramide synthase 2 in liver homeostasis: I. alterations in lipid metabolic pathways |
Q34396912 | A fusion intermediate gp41 immunogen elicits neutralizing antibodies to HIV-1 |
Q27676864 | A gp41 MPER-specific Llama VHH Requires a Hydrophobic CDR3 for Neutralization but not for Antigen Recognition |
Q67405976 | A lipid-based partitioning mechanism for selective incorporation of proteins into membranes of HIV particles. |
Q21089597 | A mechanistic paradigm for broad-spectrum antivirals that target virus-cell fusion |
Q35954283 | A molecular tweezer antagonizes seminal amyloids and HIV infection. |
Q33423858 | A raft-associated species of phosphatidylethanolamine interacts with cholesterol comparably to sphingomyelin. A Langmuir-Blodgett monolayer study |
Q42174487 | A single herpesvirus protein can mediate vesicle formation in the nuclear envelope |
Q37340812 | A strong correlation between fusogenicity and membrane insertion depth of the HIV fusion peptide |
Q30486555 | Accumulation of raft lipids in T-cell plasma membrane domains engaged in TCR signalling |
Q34306895 | All-atom models of the membrane-spanning domain of HIV-1 gp41 from metadynamics |
Q40017939 | Alteration of viral lipid composition by expression of the phospholipid floppase ABCB4 reduces HIV vector infectivity |
Q84222523 | An anti-phosphoinositide-specific monoclonal antibody that neutralizes HIV-1 infection of human monocyte-derived macrophages |
Q39795056 | Analysis of HIV-1 Gag protein interactions via biotin ligase tagging |
Q37255552 | Analysis of human immunodeficiency virus matrix domain replacements |
Q37452038 | Analysis of human immunodeficiency virus type 1 matrix binding to membranes and nucleic acids |
Q35045437 | Analysis of lipid experiments (ALEX): a software framework for analysis of high-resolution shotgun lipidomics data |
Q35886318 | Analysis of lipid-composition changes in plasma membrane microdomains |
Q36267348 | Antigenic characterization of the human immunodeficiency virus (HIV-1) envelope glycoprotein precursor incorporated into nanodiscs |
Q33422993 | Anx2 interacts with HIV-1 Gag at phosphatidylinositol (4,5) bisphosphate-containing lipid rafts and increases viral production in 293T cells |
Q33667654 | Aromatic residues at the edge of the antibody combining site facilitate viral glycoprotein recognition through membrane interactions |
Q30455050 | Assembly and architecture of HIV. |
Q97549205 | Assembly formation of minor dihydrosphingomyelin in sphingomyelin-rich ordered membrane domains |
Q37205286 | Biochemical and biologic characterization of exosomes and microvesicles as facilitators of HIV-1 infection in macrophages |
Q34509568 | Biochemical and morphological properties of hepatitis C virus particles and determination of their lipidome |
Q37058628 | Biomimetic supported lipid bilayers with high cholesterol content formed by α-helical peptide-induced vesicle fusion. |
Q27008186 | CD169-dependent cell-associated HIV-1 transmission: a driver of virus dissemination |
Q33826740 | CD317/tetherin is enriched in the HIV-1 envelope and downregulated from the plasma membrane upon virus infection |
Q28271390 | CLN3p impacts galactosylceramide transport, raft morphology, and lipid content |
Q36570805 | CRAC motif peptide of the HIV-1 gp41 protein thins SOPC membranes and interacts with cholesterol. |
Q34599188 | Capture and transfer of HIV-1 particles by mature dendritic cells converges with the exosome-dissemination pathway |
Q57080724 | Cationic liposomes are possible drug-delivery systems for HIV fusion inhibitor sifuvirtide |
Q37711566 | Caveolae provide a specialized membrane environment for respiratory syncytial virus assembly. |
Q33340974 | Cellular proteins in influenza virus particles |
Q57374026 | Characterization of lipid rafts from Medicago truncatula root plasma membranes: a proteomic study reveals the presence of a raft-associated redox system |
Q33694260 | Characterization of the water defect at the HIV-1 gp41 membrane spanning domain in bilayers with and without cholesterol using molecular simulations |
Q41855628 | Chemical shift assignment and structural plasticity of a HIV fusion peptide derivative in dodecylphosphocholine micelles |
Q92225714 | Cholesterol Binding to the Transmembrane Region of a Group 2 Hemagglutinin (HA) of Influenza Virus Is Essential for Virus Replication, Affecting both Virus Assembly and HA Fusion Activity |
Q47424542 | Cholesterol Promotes Protein Binding by Affecting Membrane Electrostatics and Solvation Properties |
Q90713380 | Cholesterol and phosphatidylethanolamine lipids exert opposite effects on membrane modulations caused by the M2 amphipathic helix |
Q58062597 | Cholesterol modulates the fusogenic activity of a membranotropic domain of the FIV glycoprotein gp36 |
Q43300786 | Cholesterol reverts Triton X-100 preferential solubilization of sphingomyelin over phosphatidylcholine: a 31P-NMR study |
Q37705129 | Cholesterol-binding viral proteins in virus entry and morphogenesis |
Q38261556 | Cholesterol-conjugated peptide antivirals: a path to a rapid response to emerging viral diseases |
Q34594591 | Cholesterol-dependent membrane fusion induced by the gp41 membrane-proximal external region-transmembrane domain connection suggests a mechanism for broad HIV-1 neutralization. |
Q39339121 | Comparative analysis of membrane-associated fusion peptide secondary structure and lipid mixing function of HIV gp41 constructs that model the early pre-hairpin intermediate and final hairpin conformations |
Q28068453 | Computational virology: From the inside out |
Q45832979 | Confocal microscopy of giant vesicles supports the absence of HIV-1 neutralizing 2F5 antibody reactivity to plasma membrane phospholipids |
Q41987173 | Conformational flexibility and strand arrangements of the membrane-associated HIV fusion peptide trimer probed by solid-state NMR spectroscopy |
Q28485911 | Conjugation of cholesterol to HIV-1 fusion inhibitor C34 increases peptide-membrane interactions potentiating its action |
Q40968325 | Cryo-electron microscopy and single molecule fluorescent microscopy detect CD4 receptor induced HIV size expansion prior to cell entry. |
Q37236615 | Crystalline polymorphism induced by charge regulation in ionic membranes |
Q35085127 | Decoding the membrane activity of the cyclotide kalata B1: the importance of phosphatidylethanolamine phospholipids and lipid organization on hemolytic and anti-HIV activities |
Q30443327 | Depletion of cellular cholesterol inhibits membrane binding and higher-order multimerization of human immunodeficiency virus type 1 Gag. |
Q92340093 | Design and Characterization of Cholesterylated Peptide HIV-1/2 Fusion Inhibitors with Extremely Potent and Long-Lasting Antiviral Activity |
Q34750051 | Detailed topology mapping reveals substantial exposure of the "cytoplasmic" C-terminal tail (CTT) sequences in HIV-1 Env proteins at the cell surface |
Q58592602 | Determining Cholesterol Binding to Membrane Proteins by Cholesterol C Labeling in Yeast and Dynamic Nuclear Polarization NMR |
Q92188514 | Development of Small-Molecule Inhibitors Against Zika Virus Infection |
Q42688106 | Dominant negative inhibition of human immunodeficiency virus particle production by the nonmyristoylated form of gag. |
Q34683447 | Dramatic potentiation of the antiviral activity of HIV antibodies by cholesterol conjugation |
Q27300214 | Dressing up Nanoparticles: A Membrane Wrap to Induce Formation of the Virological Synapse. |
Q36102200 | Dynamic Association between HIV-1 Gag and Membrane Domains. |
Q40988588 | Dynamic Reorganization and Correlation among Lipid Raft Components |
Q27316126 | Dynamics of HIV-1 assembly and release |
Q39023315 | Dynamics of intracellular processes in live-cell systems unveiled by fluorescence correlation microscopy. |
Q33810598 | Early and late HIV-1 membrane fusion events are impaired by sphinganine lipidated peptides that target the fusion site. |
Q37849655 | Early events of HIV-1 infection: can signaling be the next therapeutic target? |
Q33676508 | Effect of mutations in the human immunodeficiency virus type 1 protease on cleavage of the gp41 cytoplasmic tail |
Q38630012 | Effects of HIV-1 gp41-Derived Virucidal Peptides on Virus-like Lipid Membranes. |
Q37300342 | Effects of Membrane Charge and Order on Membrane Binding of the Retroviral Structural Protein Gag. |
Q35768114 | Effects of singlet oxygen generated by a broad-spectrum viral fusion inhibitor on membrane nanoarchitecture |
Q34201385 | Electrostatic interactions and binding orientation of HIV-1 matrix studied by neutron reflectivity |
Q64245553 | Emerging Diversity in Lipid-Protein Interactions |
Q35314176 | Encephalopathy caused by ablation of very long acyl chain ceramide synthesis may be largely due to reduced galactosylceramide levels |
Q33782563 | Energetic cost of building a virus |
Q41701451 | Envelope glycoprotein mobility on HIV-1 particles depends on the virus maturation state |
Q34149707 | Envelope lipid-packing as a critical factor for the biological activity and stability of alphavirus particles isolated from mammalian and mosquito cells. |
Q42872409 | Envelope lipids regulate the in vitro assembly of the HIV-1 capsid. |
Q26738925 | Exosomes in developmental signalling |
Q38034222 | Extracellular vesicles and their convergence with viral pathways |
Q36090878 | Flagellar membranes are rich in raft-forming phospholipids |
Q34579843 | Folded monomers and hexamers of the ectodomain of the HIV gp41 membrane fusion protein: potential roles in fusion and synergy between the fusion peptide, hairpin, and membrane-proximal external region |
Q28828700 | Functional organization of the HIV lipid envelope |
Q30419302 | Fusion activity of HIV gp41 fusion domain is related to its secondary structure and depth of membrane insertion in a cholesterol-dependent fashion |
Q35091283 | Fusion-competent state induced by a C-terminal HIV-1 fusion peptide in cholesterol-rich membranes |
Q35382894 | Gag induces the coalescence of clustered lipid rafts and tetraspanin-enriched microdomains at HIV-1 assembly sites on the plasma membrane. |
Q37308716 | Global rescue of defects in HIV-1 envelope glycoprotein incorporation: implications for matrix structure |
Q90117404 | Glucocerebrosidases catalyze a transgalactosylation reaction that yields a newly identified brain sterol metabolite, galactosylated cholesterol |
Q37145333 | Glycosphingolipid composition of human immunodeficiency virus type 1 (HIV-1) particles is a crucial determinant for dendritic cell-mediated HIV-1 trans-infection |
Q33943688 | Glycosphingolipid-functionalized nanoparticles recapitulate CD169-dependent HIV-1 uptake and trafficking in dendritic cells |
Q64101637 | HCV Pit Stop at the Lipid Droplet: Refuel Lipids and Put on a Lipoprotein Coat before Exit |
Q33548656 | HIV and mature dendritic cells: Trojan exosomes riding the Trojan horse? |
Q34435855 | HIV entry and envelope glycoprotein-mediated fusion |
Q45357578 | HIV entry in macrophages is dependent on intact lipid rafts |
Q42196734 | HIV fusion peptide and its cross-linked oligomers: efficient syntheses, significance of the trimer in fusion activity, correlation of beta strand conformation with membrane cholesterol, and proximity to lipid headgroups |
Q34131438 | HIV fusion peptide penetrates, disorders, and softens T-cell membrane mimics. |
Q37533454 | HIV gp41 fusion peptide increases membrane ordering in a cholesterol-dependent fashion |
Q41889237 | HIV gp41 six-helix bundle constructs induce rapid vesicle fusion at pH 3.5 and little fusion at pH 7.0: understanding pH dependence of protein aggregation, membrane binding, and electrostatics, and implications for HIV-host cell fusion |
Q27312411 | HIV gp41-mediated membrane fusion occurs at edges of cholesterol-rich lipid domains |
Q33361587 | HIV replication enhances production of free fatty acids, low density lipoproteins and many key proteins involved in lipid metabolism: a proteomics study |
Q24614498 | HIV type 1 Gag as a target for antiviral therapy |
Q37178360 | HIV-1 Assembly at the Plasma Membrane: Gag Trafficking and Localization |
Q59357633 | HIV-1 Env gp41 Transmembrane Domain Dynamics Are Modulated by Lipid, Water, and Ion Interactions |
Q30397032 | HIV-1 Gag extension: conformational changes require simultaneous interaction with membrane and nucleic acid |
Q36414941 | HIV-1 Gag protein can sense the cholesterol and acyl chain environment in model membranes |
Q90735552 | HIV-1 Gag specifically restricts PI(4,5)P2 and cholesterol mobility in living cells creating a nanodomain platform for virus assembly |
Q59360984 | HIV-1 Matrix Protein Interactions with tRNA: Implications for Membrane Targeting |
Q43236402 | HIV-1 Nef membrane association depends on charge, curvature, composition and sequence. |
Q38975605 | HIV-1 antibodies and vaccine antigen selectively interact with lipid domains. |
Q33814340 | HIV-1 assembly differentially alters dynamics and partitioning of tetraspanins and raft components |
Q38023864 | HIV-1 assembly, budding, and maturation |
Q38539565 | HIV-1 assembly, release and maturation. |
Q33279812 | HIV-1 buds predominantly at the plasma membrane of primary human macrophages |
Q35208189 | HIV-1 capture and transmission by dendritic cells: the role of viral glycolipids and the cellular receptor Siglec-1 |
Q46617628 | HIV-1 counteracts an innate restriction by amyloid precursor protein resulting in neurodegeneration |
Q35850220 | HIV-1 escape from the entry-inhibiting effects of a cholesterol-binding compound via cleavage of gp41 by the viral protease |
Q35982750 | HIV-1 incorporation of host-cell-derived glycosphingolipid GM3 allows for capture by mature dendritic cells. |
Q27345288 | HIV-1 matrix dependent membrane targeting is regulated by Gag mRNA trafficking |
Q37187498 | HIV-1 matrix organizes as a hexamer of trimers on membranes containing phosphatidylinositol-(4,5)-bisphosphate |
Q34001144 | HIV-1, lipid rafts, and antibodies to liposomes: implications for anti-viral-neutralizing antibodies |
Q37257389 | HM1.24 is internalized from lipid rafts by clathrin-mediated endocytosis through interaction with alpha-adaptin |
Q42667010 | Hairpin folding of HIV gp41 abrogates lipid mixing function at physiologic pH and inhibits lipid mixing by exposed gp41 constructs |
Q27485703 | Hepatitis C virus NS5A anchor peptide disrupts human immunodeficiency virus |
Q39119590 | Hepatitis C virus infection propagates through interactions between Syndecan-1 and CD81 and impacts the hepatocyte glycocalyx. |
Q42977206 | High plasma level of nucleocapsid-free envelope glycoprotein-positive lipoproteins in hepatitis C patients |
Q35134904 | High-content screening of yeast mutant libraries by shotgun lipidomics |
Q42248176 | High-fidelity protein targeting into membrane lipid microdomains in living cells |
Q90411797 | Highlight article: The role of cholesterol and cholesterol-driven membrane raft domains in prostate cancer |
Q90287100 | Histidine-Rich Glycoprotein Inhibits HIV-1 Infection in a pH-Dependent Manner |
Q38117580 | Histone deacetylases in herpesvirus replication and virus-stimulated host defense |
Q57351162 | Host-Pathogen interactions: Lipids grease the way |
Q42579264 | Host-encoded reporters for the detection and purification of multiple enveloped viruses |
Q28278490 | How HIV finds the door |
Q57351153 | How do sphingolipids and lipid rafts relate to pathology? |
Q39779756 | Human immunodeficiency virus type 1 Nef protein modulates the lipid composition of virions and host cell membrane microdomains |
Q30480954 | Human immunodeficiency virus type 1 and influenza virus exit via different membrane microdomains. |
Q36857103 | Human immunodeficiency virus type 1 assembly, release, and maturation. |
Q34485169 | Identification of amino acids in the human tetherin transmembrane domain responsible for HIV-1 Vpu interaction and susceptibility |
Q35894459 | Identification of mumps virus protein and lipid composition by mass spectrometry. |
Q37338014 | Identification of pauses during formation of HIV-1 virus like particles |
Q34106567 | Imaging lipid lateral organization in membranes with C-laurdan in a confocal microscope |
Q35745442 | Immunogenic Display of Purified Chemically Cross-Linked HIV-1 Spikes |
Q37183472 | Impact of HIV-1 Membrane Cholesterol on Cell-Independent Lytic Inactivation and Cellular Infectivity |
Q37709593 | Implications for lipids during replication of enveloped viruses |
Q33773066 | In vitro membrane reconstitution of the T-cell receptor proximal signaling network |
Q34517381 | Inhibition of HIV Entry by Targeting the Envelope Transmembrane Subunit gp41. |
Q57372518 | Inhibition of HIV-1 Replication by Amphotericin B Methyl Ester |
Q36898892 | Inhibition of human immunodeficiency virus type 1 assembly and release by the cholesterol-binding compound amphotericin B methyl ester: evidence for Vpu dependence |
Q37067907 | Interfacial pre-transmembrane domains in viral proteins promoting membrane fusion and fission. |
Q34671896 | Interferon-inducible mechanism of dendritic cell-mediated HIV-1 dissemination is dependent on Siglec-1/CD169. |
Q41712949 | Involvement of the Rac1-IRSp53-Wave2-Arp2/3 Signaling Pathway in HIV-1 Gag Particle Release in CD4 T Cells |
Q58451687 | La mystérieuse cible de la protéine virale Nef identifiée : les protéines SERINC3 et SERINC5 |
Q37155975 | Large changes in the CRAC segment of gp41 of HIV do not destroy fusion activity if the segment interacts with cholesterol |
Q30424853 | Large membrane domains in hair bundles specify spatially constricted radixin activation |
Q27318758 | Line tension at lipid phase boundaries as driving force for HIV fusion peptide-mediated fusion |
Q55618803 | Lipid Biomarkers in Acute Myocardial Infarction Before and After Percutaneous Coronary Intervention by Lipidomics Analysis. |
Q58795142 | Lipid Composition but Not Curvature Is the Determinant Factor for the Low Molecular Mobility Observed on the Membrane of Virus-Like Vesicles |
Q90729693 | Lipid Rafts and Pathogens: The Art of Deception and Exploitation |
Q52650999 | Lipid biosensor interactions with wild type and matrix deletion HIV-1 Gag proteins. |
Q40961355 | Lipid composition of viral envelope of three strains of influenza virus - not all viruses are created equal. |
Q38218105 | Lipid domains in HIV-1 assembly |
Q36287539 | Lipid interactions and angle of approach to the HIV-1 viral membrane of broadly neutralizing antibody 10E8: Insights for vaccine and therapeutic design. |
Q46310805 | Lipid modulation of membrane-bound epitope recognition and blocking by HIV-1 neutralizing antibodies |
Q36768730 | Lipid rafts and membrane traffic |
Q38859756 | Lipid rafts both in cellular membrane and viral envelope are critical for PRRSV efficient infection. |
Q36828184 | Lipid-Mediated Targeting with Membrane-Wrapped Nanoparticles in the Presence of Corona Formation |
Q37006808 | Lipidome analysis of rotavirus-infected cells confirms the close interaction of lipid droplets with viroplasms |
Q63740106 | Lipidomic Analysis Reveals Serum Alteration of Plasmalogens in Patients Infected With ZIKA Virus |
Q33528351 | Lipidomic study of intracellular Singapore grouper iridovirus |
Q36543297 | Lipidomics of host-pathogen interactions |
Q37456273 | Lipidomics: a mass spectrometry based systems level analysis of cellular lipids |
Q57008156 | Lipidomimetic Compounds Act as HIV-1 Entry Inhibitors by Altering Viral Membrane Structure |
Q37855539 | Lipids and membrane lateral organization |
Q27489393 | Lipids and membrane microdomains in HIV-1 replication |
Q28253198 | Lipids in host-pathogen interactions: pathogens exploit the complexity of the host cell lipidome |
Q36069704 | Localization of sphingomyelin in cholesterol domains by imaging mass spectrometry |
Q35635168 | Lysis of human immunodeficiency virus type 1 by a specific secreted human phospholipase A2 |
Q34931267 | Macrophages and Cell-Cell Spread of HIV-1. |
Q41296567 | Major antiparallel and minor parallel β sheet populations detected in the membrane-associated human immunodeficiency virus fusion peptide |
Q34365214 | Mass spectrometric approaches to study enveloped viruses: new possibilities for structural biology and prophylactic medicine |
Q37359745 | Maturation of the Gag core decreases the stability of retroviral lipid membranes |
Q37547462 | Mechanism of HIV-1 neutralization by antibodies targeting a membrane-proximal region of gp41. |
Q37988058 | Mechanism of function of viral channel proteins and implications for drug development |
Q88615671 | Membrane Bending Moduli of Coexisting Liquid Phases Containing Transmembrane Peptide |
Q36811852 | Membrane Binding of HIV-1 Matrix Protein: Dependence on Bilayer Composition and Protein Lipidation |
Q41933114 | Membrane Fluidity Sensing on the Single Virus Particle Level with Plasmonic Nanoparticle Transducers. |
Q21131091 | Membrane binding and bending in Ebola VP40 assembly and egress |
Q35007633 | Membrane budding |
Q38042116 | Membrane dynamics and interactions in measles virus dendritic cell infections |
Q28069980 | Membrane dynamics associated with viral infection |
Q33720525 | Membrane fission reactions of the mammalian ESCRT pathway |
Q38210206 | Membrane interaction of retroviral Gag proteins |
Q34549906 | Membrane lipidome of an epithelial cell line |
Q39649986 | Membrane raft association of the Vpu protein of human immunodeficiency virus type 1 correlates with enhanced virus release |
Q37663092 | Membrane rafting: from apical sorting to phase segregation |
Q37078294 | Membrane structure correlates to function of LLP2 on the cytoplasmic tail of HIV-1 gp41 protein |
Q39625778 | Membrane topology analysis of HIV-1 envelope glycoprotein gp41 |
Q35556337 | Membrane-proximal external HIV-1 gp41 motif adapted for destabilizing the highly rigid viral envelope |
Q59353163 | Membrane-wrapped nanoparticles probe divergent roles of GM3 and phosphatidylserine in lipid-mediated viral entry pathways |
Q46502868 | Microquantification of phospholipid classes by stable isotope dilution and nanoESI mass spectrometry |
Q26823408 | Microvesicles and viral infection |
Q38137053 | Model cell membranes: Techniques to form complex biomimetic supported lipid bilayers via vesicle fusion |
Q96223358 | Modeling and Simulation of a Fully-glycosylated Full-length SARS-CoV-2 Spike Protein in a Viral Membrane |
Q33804191 | Molecular dynamics exploration of poration and leaking caused by Kalata B1 in HIV-infected cell membrane compared to host and HIV membranes |
Q60917642 | Molecular recognition of the native HIV-1 MPER revealed by STED microscopy of single virions |
Q36791778 | More than one door - Budding of enveloped viruses through cellular membranes |
Q28550514 | Morphology and Molecular Composition of Purified Bovine Viral Diarrhea Virus Envelope |
Q36283824 | Mouse Siglec-1 Mediates trans-Infection of Surface-bound Murine Leukemia Virus in a Sialic Acid N-Acyl Side Chain-dependent Manner |
Q43426984 | Multimerizable HIV Gag derivative binds to the liquid-disordered phase in model membranes |
Q35027097 | Multiple locations of peptides in the hydrocarbon core of gel-phase membranes revealed by peptide (13)C to lipid (2)H rotational-echo double-resonance solid-state nuclear magnetic resonance |
Q41940316 | Mutation of a single residue, beta-glutamate-20, alters protein-lipid interactions of light harvesting complex II. |
Q34146122 | Mutation of the ATP Cassette Binding Transporter A1 (ABCA1) C-Terminus Disrupts HIV-1 Nef Binding but Does Not Block the Nef Enhancement of ABCA1 Protein Degradation |
Q35675988 | NMR structure of the myristylated feline immunodeficiency virus matrix protein |
Q36307738 | New insights into HIV assembly and trafficking |
Q33624690 | Novel approaches to inhibiting HIV-1 replication. |
Q42249670 | Novel molecular determinants of viral susceptibility and resistance in the lipidome of Emiliania huxleyi |
Q42929024 | Nuclear magnetic resonance evidence for retention of a lamellar membrane phase with curvature in the presence of large quantities of the HIV fusion peptide |
Q27312753 | Nucleocapsid promotes localization of HIV-1 gag to uropods that participate in virological synapses between T cells |
Q96781879 | Omics-Driven Systems Interrogation of Metabolic Dysregulation in COVID-19 Pathogenesis |
Q36343288 | Optimized method for computing (18)O/(16)O ratios of differentially stable-isotope labeled peptides in the context of postdigestion (18)O exchange/labeling |
Q47439208 | Organization and evolution of brain lipidome revealed by large-scale analysis of human, chimpanzee, macaque, and mouse tissues |
Q38006719 | Palmitoylation of virus proteins |
Q30525336 | Phosphatidylethanolamine binding is a conserved feature of cyclotide-membrane interactions |
Q37592327 | Plasma membrane rafts engaged in T cell signalling: new developments in an old concept |
Q40135865 | Plasmonic Nanohole Sensor for Capturing Single Virus-Like Particles toward Virucidal Drug Evaluation |
Q42554823 | Polymer-supported lipid shells, onions, and flowers. |
Q34267975 | Poxvirus membrane biogenesis: rupture not disruption |
Q39833520 | Probing HIV-1 membrane liquid order by Laurdan staining reveals producer cell-dependent differences. |
Q40718426 | Properties of HIV-1 associated cholesterol in addition to raft formation are important for virus infection. |
Q40074168 | Protein-sphingolipid interactions within cellular membranes |
Q37584635 | Proteoliposomal formulations of an HIV-1 gp41-based miniprotein elicit a lipid-dependent immunodominant response overlapping the 2F5 binding motif. |
Q91496683 | Quantification of phosphoinositides reveals strong enrichment of PIP2 in HIV-1 compared to producer cell membranes |
Q35659750 | Quantifying lipid contents in enveloped virus particles with plasmonic nanoparticles |
Q33935579 | Quantitative analysis of glycerophospholipids by LC-MS: acquisition, data handling, and interpretation |
Q35694152 | Quantitative analysis of the lipidomes of the influenza virus envelope and MDCK cell apical membrane |
Q35210688 | REDOR solid-state NMR as a probe of the membrane locations of membrane-associated peptides and proteins |
Q39826186 | Reactivation from latency displays HIV particle budding at plasma membrane, accompanying CD44 upregulation and recruitment |
Q51802993 | Recognition and blocking of HIV-1 gp41 pre-transmembrane sequence by monoclonal 4E10 antibody in a Raft-like membrane environment. |
Q39719312 | Recognition of decay accelerating factor and alpha(v)beta(3) by inactivated hantaviruses: Toward the development of high-throughput screening flow cytometry assays |
Q39591713 | Recombinant heptameric coatomer complexes: novel tools to study isoform-specific functions |
Q34666503 | Relationships between plasma membrane microdomains and HIV-1 assembly |
Q43053935 | Residue-specific membrane location of peptides and proteins using specifically and extensively deuterated lipids and ¹³C-²H rotational-echo double-resonance solid-state NMR. |
Q37850839 | Retroviral matrix and lipids, the intimate interaction |
Q36949766 | Retroviruses human immunodeficiency virus and murine leukemia virus are enriched in phosphoinositides. |
Q37791416 | Revitalizing membrane rafts: new tools and insights |
Q38227871 | Role of Gag and lipids during HIV-1 assembly in CD4(+) T cells and macrophages. |
Q37453499 | Role of HIV membrane in neutralization by two broadly neutralizing antibodies |
Q36940332 | Role of glycosphingolipids in dendritic cell-mediated HIV-1 trans-infection |
Q37316019 | Role of lipid structure in the humoral immune response in mice to covalent lipid-peptides from the membrane proximal region of HIV-1 gp41. |
Q37882865 | Role of lipids in virus replication |
Q39545996 | Role of sulfatide in vaccinia virus infection. |
Q59794597 | Role of the Ebola membrane in the protection conferred by the three-mAb cocktail MIL77 |
Q37858901 | Roles for biological membranes in regulating human immunodeficiency virus replication and progress in the development of HIV therapeutics that target lipid metabolism. |
Q37192594 | Roles of the interactions between Env and Gag proteins in the HIV-1 replication cycle |
Q38631942 | Rous sarcoma virus gag has no specific requirement for phosphatidylinositol-(4,5)-bisphosphate for plasma membrane association in vivo or for liposome interaction in vitro. |
Q47550082 | SERINC as a Restriction Factor to Inhibit Viral Infectivity and the Interaction with HIV. |
Q34980423 | Segregation of sphingolipids and sterols during formation of secretory vesicles at the trans-Golgi network |
Q34390521 | Self-enhancement of hepatitis C virus replication by promotion of specific sphingolipid biosynthesis |
Q42183231 | Self-segregation of myelin membrane lipids in model membranes |
Q39258110 | Sequences within RNA coding for HIV-1 Gag p17 are efficiently targeted to exosomes |
Q27319569 | Sialyllactose in viral membrane gangliosides is a novel molecular recognition pattern for mature dendritic cell capture of HIV-1 |
Q91886630 | Similarities and differences between native HIV-1 envelope glycoprotein trimers and stabilized soluble trimer mimetics |
Q39075399 | Simultaneous Analysis of Secondary Structure and Light Scattering from Circular Dichroism Titrations: Application to Vectofusin-1. |
Q41534544 | Solid-state NMR spectroscopy of human immunodeficiency virus fusion peptides associated with host-cell-like membranes: 2D correlation spectra and distance measurements support a fully extended conformation and models for specific antiparallel strand |
Q42003499 | Solid-state NMR spectroscopy of the HIV gp41 membrane fusion protein supports intermolecular antiparallel β sheet fusion peptide structure in the final six-helix bundle state |
Q56979426 | Solid-state nuclear magnetic resonance (NMR) spectroscopy of human immunodeficiency virus gp41 protein that includes the fusion peptide: NMR detection of recombinant Fgp41 in inclusion bodies in whole bacterial cells and structural characterization o |
Q41973824 | Solid-state nuclear magnetic resonance measurements of HIV fusion peptide 13CO to lipid 31P proximities support similar partially inserted membrane locations of the α helical and β sheet peptide structures |
Q42009823 | Solid-state nuclear magnetic resonance measurements of HIV fusion peptide to lipid distances reveal the intimate contact of beta strand peptide with membranes and the proximity of the Ala-14-Gly-16 region with lipid headgroups |
Q40242493 | Specific and distinct determinants mediate membrane binding and lipid raft incorporation of HIV-1(SF2) Nef. |
Q90854406 | Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication |
Q39683455 | Sphingolipid rheostat alterations related to transformation can be exploited for specific induction of lysosomal cell death in murine and human glioma |
Q90460876 | Sphingolipids as Potential Therapeutic Targets against Enveloped Human RNA Viruses |
Q99557052 | Sphingomyelin Is Essential for the Structure and Function of the Double-Membrane Vesicles in the Viral RNA Replication Factories |
Q36533617 | Sphingomyelin organization is required for vesicle biogenesis at the Golgi complex. |
Q36329809 | Sphingopeptides: dihydrosphingosine-based fusion inhibitors against wild-type and enfuvirtide-resistant HIV-1 |
Q35996098 | Sphingosine-1-Phosphate Lyase Deficient Cells as a Tool to Study Protein Lipid Interactions |
Q40857639 | Spotlight on HIV-1 Nef: SERINC3 and SERINC5 Identified as Restriction Factors Antagonized by the Pathogenesis Factor |
Q37663101 | Stability of lipid domains |
Q34051644 | Stimulation of the liver X receptor pathway inhibits HIV-1 replication via induction of ATP-binding cassette transporter A1 |
Q46324256 | Stored platelets alter glycerophospholipid and sphingolipid species, which are differentially transferred to newly released extracellular vesicles |
Q27680872 | Structural Basis for HIV-1 Neutralization by 2F5-Like Antibodies m66 and m66.6 |
Q36812591 | Structural and Molecular Determinants of Membrane Binding by the HIV-1 Matrix Protein |
Q27665971 | Structural and biochemical consequences of NF1 associated nontruncating mutations in the Sec14-PH module of neurofibromin |
Q55440361 | Super-resolution fluorescence microscopy studies of human immunodeficiency virus. |
Q34611178 | Super-resolution microscopy reveals specific recruitment of HIV-1 envelope proteins to viral assembly sites dependent on the envelope C-terminal tail. |
Q38818374 | Super-resolved insights into human immunodeficiency virus biology. |
Q40175971 | Synchronized HIV assembly by tunable PIP2 changes reveals PIP2 requirement for stable Gag anchoring. |
Q81584335 | Synthetic peptide AT20 coupled to KLH elicits antibodies against a conserved conformational epitope from a major functional area of the HIV-1 matrix protein p17 |
Q35659568 | Target silencing of components of the conserved oligomeric Golgi complex impairs HIV-1 replication |
Q38371073 | Targeting of the hydrophobic metabolome by pathogens. |
Q27490520 | Temporal Proteome and Lipidome Profiles Reveal Hepatitis C Virus-Associated Reprogramming of Hepatocellular Metabolism and Bioenergetics |
Q29547836 | Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu |
Q38940969 | The Continuing Mystery of Lipid Rafts |
Q37959034 | The Nef-infectivity enigma: mechanisms of enhanced lentiviral infection |
Q59132140 | The Role of Host Cholesterol During Flavivirus Infection |
Q34080779 | The Role of Lipids in Retrovirus Replication |
Q38816571 | The Role of the Membrane in the Structure and Biophysical Robustness of the Dengue Virion Envelope. |
Q38657257 | The biophysical properties of plasmalogens originating from their unique molecular architecture. |
Q36898696 | The broadly neutralizing anti-human immunodeficiency virus type 1 4E10 monoclonal antibody is better adapted to membrane-bound epitope recognition and blocking than 2F5. |
Q46268604 | The ceramide structure of GM1 ganglioside differently affects its recovery in low-density membrane fractions prepared from HL-60 cells with or without triton-X100. |
Q24652892 | The challenge of lipid rafts |
Q38993416 | The cholesterol-binding motif of the HIV-1 glycoprotein gp41 regulates lateral sorting and oligomerization. |
Q30588461 | The composition of West Nile virus lipid envelope unveils a role of sphingolipid metabolism in flavivirus biogenesis. |
Q36940646 | The frantic play of the concealed HIV envelope cytoplasmic tail. |
Q27936543 | The genetic interactome of prohibitins: coordinated control of cardiolipin and phosphatidylethanolamine by conserved regulators in mitochondria |
Q40142057 | The host-cell restriction factor SERINC5 restricts HIV-1 infectivity without altering the lipid composition and organization of viral particles |
Q36282554 | The improved efficacy of Sifuvirtide compared with enfuvirtide might be related to its selectivity for the rigid biomembrane, as determined through surface plasmon resonance |
Q37275121 | The lipidomes of vesicular stomatitis virus, semliki forest virus, and the host plasma membrane analyzed by quantitative shotgun mass spectrometry |
Q50082627 | The molecular tweezer CLR01 inhibits Ebola and Zika virus infection. |
Q38021263 | The origin of genetic diversity in HIV-1. |
Q33796306 | The roles of tetraspanins in HIV-1 replication |
Q34137493 | The scaffolding protein Dlg1 is a negative regulator of cell-free virus infectivity but not of cell-to-cell HIV-1 transmission in T cells |
Q36708965 | Translational control of retroviruses. |
Q35992621 | Translational research in infectious disease: current paradigms and challenges ahead |
Q35842299 | Transmembrane domain membrane proximal external region but not surface unit-directed broadly neutralizing HIV-1 antibodies can restrict dendritic cell-mediated HIV-1 trans-infection |
Q36950860 | Trimer Enhancement Mutation Effects on HIV-1 Matrix Protein Binding Activities |
Q27676343 | Trio engagement via plasma membrane phospholipids and the myristoyl moiety governs HIV-1 matrix binding to bilayers |
Q33950318 | Understanding lipid rafts and other related membrane domains |
Q33990602 | Viral entry inhibitors targeted to the membrane site of action. |
Q35011506 | Viral glycosphingolipids induce lytic infection and cell death in marine phytoplankton. |
Q36770718 | Viral serine palmitoyltransferase induces metabolic switch in sphingolipid biosynthesis and is required for infection of a marine alga |
Q41882804 | Virion stiffness regulates immature HIV-1 entry |
Q91693235 | Virucidal Activity of Gold Nanoparticles Synthesized by Green Chemistry Using Garlic Extract |
Q38044517 | Virus assembly and plasma membrane domains: which came first? |
Q36744226 | Virus membrane fusion |
Q30944807 | Virus movements on the plasma membrane support infection and transmission between cells |
Q34059163 | Virus particle release from glycosphingolipid-enriched microdomains is essential for dendritic cell-mediated capture and transfer of HIV-1 and henipavirus. |
Q33677540 | Viruses and tetraspanins: lessons from single molecule approaches |
Q37681125 | Viruses as vesicular carriers of the viral genome: a functional module perspective. |
Q27486120 | West Nile Virus Entry Requires Cholesterol-Rich Membrane Microdomains and Is Independent of v 3 Integrin |
Q42202737 | pH-dependent vesicle fusion induced by the ectodomain of the human immunodeficiency virus membrane fusion protein gp41: Two kinetically distinct processes and fully-membrane-associated gp41 with predominant β sheet fusion peptide conformation |
Search more.